The Official @Labroots Cancer Research Page! We are here to discuss the most recent advances in cancer research and therapeutics. Please join our community! 馃帡

Joined January 2014
馃К Smarter cancer genomics workflows, from sample to insight. Join Day 2 of the Agilent Oncology Research Summit. 馃搮 3 Nov | 馃晳 14:00 CET | 馃捇 Virtual buff.ly/q6Elbcq
16
Attending #SITC2026, hear Jeremiah Wala (Dana-Farber) present Orion spatial proteomics findings from a colorectal cancer immunotherapy trial. Nov 6, 6:45 PM | Exhibit Hall Visit @RareCyte Booth #1120! buff.ly/JhhNGxO
33
馃敩 Agilent Oncology Research Summit 2026: two virtual sessions on molecular oncology, cancer genomics & precision medicine. 馃搮 Session 1 - Oct 29 : Molecular Oncology & Genomics 馃搮 Session 2 - Oct 15 : Integrated Oncology Workflows Sign up now: buff.ly/hu5B70D
32
Join us on Nov. 5th for Emerging Tools for Functional Cell Sorting, an educational virtual event exploring how new large-particle workflows are expanding the possibilities of flow cytometry-based analysis and sorting. Register now: buff.ly/CnuoOqt
37
Not all multiplex immunofluorescence technologies are designed for the same objective. This guide compares the main categories and explains which workflows are best for discovery, biomarker development, and clinical research. buff.ly/IG6Pwv0
29
The ovary has long been treated as an inert organ once menopause is over. 馃懙 A proteomic analysis of 28 donated ovaries found that they keep changing for decades afterward. 馃攷 buff.ly/ZBPALSk
23
Gene鈥憁odified CAR T cell therapies are transforming cancer treatment, but variability and manufacturing challenges remain. Discover high鈥憈hroughput strategies to characterize CAR T cells鈥攁ctivation, memory, exhaustion, cytokines, and killing. buff.ly/UvjkAwK
19
Doctors usually wait for cancer to appear before transplanting bone marrow in patients living with Shwachman-Diamond syndrome, a rare genetic disease. New data suggest that may be too late. buff.ly/nlGNFiV
43
See how 3D spheroid models and live-cell analysis were used to profile 880 FDA-approved compounds, uncovering cytotoxic, cytostatic, and disruptive responses. Learn how 3D assays can deliver richer data and improve in vitro to in vivo translation. buff.ly/qX19AVC
34
Not all multiplex immunofluorescence technologies are designed for the same objective. This guide compares the main categories and explains which workflows are best for discovery, biomarker development, and clinical research. buff.ly/6xVZBFh
34